InflaRx (IFRX) Interest Coverage Ratio Growth (1y) (2017 - 2026)
InflaRx (IFRX) Interest Coverage Ratio Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
67.94% |
| 10 |
InflaRx |
764.68 Mn |
764.68 Mn |
10,877.40 |
-84.71% |
| Date | Value |
|---|
| Mar 31, 2026 |
-84.71% |
| Dec 31, 2025 |
-51.01% |
| Sep 30, 2025 |
-78.38% |
| Jun 30, 2025 |
118.37% |
| Mar 31, 2025 |
18.05% |
| Dec 31, 2024 |
554.65% |
| Sep 30, 2024 |
34.05% |
| Jun 30, 2024 |
-9.62% |
| Mar 31, 2024 |
140,676,646,727,929.61% |
| Dec 31, 2023 |
-119.87% |
| Sep 30, 2023 |
181,361,252,269,456.53% |
| Jun 30, 2023 |
1,326.41% |
| Mar 31, 2023 |
-100.00% |
| Dec 31, 2022 |
249,797,317.00% |
| Sep 30, 2022 |
-100.00% |
| Jun 30, 2022 |
-97.02% |
| Mar 31, 2022 |
-71.90% |
| Dec 31, 2021 |
100.00% |
| Sep 30, 2021 |
108.42% |
| Jun 30, 2021 |
48.80% |
